Knights of Columbus Asset Advisors LLC Has $535,000 Stock Holdings in DaVita Inc. (NYSE:DVA)

Knights of Columbus Asset Advisors LLC trimmed its position in DaVita Inc. (NYSE:DVA) by 44.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,579 shares of the company’s stock after selling 2,845 shares during the period. Knights of Columbus Asset Advisors LLC’s holdings in DaVita were worth $535,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of DVA. Franklin Resources Inc. increased its stake in DaVita by 134.6% during the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock worth $8,885,000 after purchasing an additional 31,502 shares in the last quarter. FMR LLC increased its stake in DaVita by 659.9% during the 3rd quarter. FMR LLC now owns 177,406 shares of the company’s stock worth $29,082,000 after purchasing an additional 154,061 shares in the last quarter. Atom Investors LP bought a new stake in DaVita during the 3rd quarter worth approximately $4,094,000. Assenagon Asset Management S.A. increased its stake in DaVita by 201.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock worth $11,159,000 after purchasing an additional 49,885 shares in the last quarter. Finally, Neo Ivy Capital Management bought a new stake in DaVita during the 3rd quarter worth approximately $726,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on DVA. Barclays increased their target price on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th. StockNews.com cut DaVita from a “buy” rating to a “hold” rating in a research note on Friday. Sanford C. Bernstein set a $184.00 price target on shares of DaVita in a research note on Friday, February 21st. Finally, Cowen reaffirmed a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, DaVita has an average rating of “Hold” and a consensus target price of $166.33.

DaVita Price Performance

Shares of DVA opened at $148.25 on Friday. The stock has a market capitalization of $11.86 billion, a P/E ratio of 13.80, a P/E/G ratio of 1.07 and a beta of 0.99. DaVita Inc. has a twelve month low of $125.64 and a twelve month high of $179.60. The company has a 50 day moving average of $158.53 and a 200-day moving average of $157.51. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA) last released its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, equities research analysts forecast that DaVita Inc. will post 10.76 EPS for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.